NYR vs OCC

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

NYR

NYRADA CDI FORUS [NYR]

52MEDIUM

OCC

ORTHOCELL FPO [OCC]

52MEDIUM

Score Breakdown

NYR OCC
Technical
47
45
Catalyst
49
55
Sentiment
50
50
Fundamental
46
83
Momentum
67
50
Risk Gate
42
45

Key Metrics

NYR Metric OCC
$101.3MMarket Cap$222.8M
185KAvg Volume (20d)527K
N/AShort Interest+0.4%
$1.43552-Week High$1.600
$0.22552-Week Low$0.700
-2.4%Daily Change-6.5%
$0.400Entry Price$0.795
-71.0%ROE-41.1%
-234.3%Profit Margin-133.8%

Active Signals

NYR Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Sitting near support — this level has held before and could attract buyers again
●Drifting lower — down 4.8% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (4 quarters) - dilution risk
●Piotroski F-Score weak (3/9, low-confidence approx)

OCC Signals

●Drifting lower — down 5.9% over the last 5 days
●Beating the Small Ords index — relative strength of 1.11, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (15 quarters)
●4C filed 2026-07-12
●Strong revenue growth (+49%)
●EPS estimates revised upward (+10pts)
●Near 52-week low (13% of range)

Ask Scout AI to compare NYR and OCC in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
NYR Full Analysis → OCC Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).